Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
At The Market Offering With Maxim
February 2025 Offering
Common Shares
Common Shares
At The Market Offering With Maxim
Common Shares
February 2025 Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering With Maxim
Additional Paid-in Capital
February 2025 Offering
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2024       52,034,060            
Beginning Balance at Dec. 31, 2024 $ 85,726     $ 5     $ 384,172     $ (298,451)
Equity                    
Stock-based compensation (in shares)       5,986,893            
Stock-based compensation $ 648           648      
Issuance of common stock in connection with the equity offering, net of fees (in shares)           4,757,126        
Issuance of common stock in connection with the Equity offering, net of fees     $ 4,860     $ 1     $ 4,859  
Issuance of common stock in connection with warrant exercise (in shares) 3,246,111     3,246,111            
Conversion of liability warrants to equity warrants $ 15           15      
Net loss (9,563)                 (9,563)
Ending Balance (in shares) at Mar. 31, 2025       66,024,190            
Ending Balance at Mar. 31, 2025 81,686     $ 6     389,694     (308,014)
Beginning Balance (in shares) at Dec. 31, 2025       573,438,153            
Beginning Balance at Dec. 31, 2025 237,974 [1]     $ 59     615,360     (377,445)
Equity                    
Stock-based compensation (in shares)       211,131            
Stock-based compensation 5,234           5,234      
Equity issuance costs (250)           (250)      
Issuance of common stock for intangible assets acquisition (in shares)       7,500,000            
Issuance of common stock for intangible asset acquisition 5,401     $ 1     5,400      
Issuance of common stock in connection with the equity offering, net of fees (in shares)   36,663,892     36,663,892          
Issuance of common stock in connection with the Equity offering, net of fees   $ 24,800     $ 3     $ 24,797    
Net loss (53,131)                 (53,131)
Ending Balance (in shares) at Mar. 31, 2026       617,813,176            
Ending Balance at Mar. 31, 2026 $ 220,028     $ 63     $ 650,541     $ (430,576)
[1] The condensed consolidated balance sheet as of December 31, 2025 was derived from the audited consolidated balance sheet as of that date.